VE
Verve
VERV·NASDAQBoston MAFounded 2018250 employees
Small CapbiotechPublicCardiology
Platform: Base Edit CV
Market Cap
$1.1B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (VERV)
Loading VERV stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixabrutinib | VER-4713 | Phase 1 | 1 | RET | T2D | ||
| Doxacagene | VER-4971 | Phase 1/2 | 1 | C5 | Pancreatic CaMigraine |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)